Biostar Pharmaceuticals, Inc. (BSPM.OB) Receives Patent for Aoxing Ganbao
Biostar Pharmaceuticals, Inc., a developer, manufacturer and marketer of pharmaceutical and medical nutrient products for a variety of diseases and conditions in China, recently announced that the company has received a patent from China’s State Intellectual Property Bureau (patent number 551073) for its Aoxing Ganbao product, a traditional Chinese herbal product to treat Hepatitis B. Used as a complementary treatment for the company’s flagship Xin Aoxing Oleanolic Acid Capsule, Ganbao is applied topically to effectively combat Hepatitis B conditions by nourishing the liver and reducing inflammation without side effects. The retail price of Aoxing Ganbao is $20 with a gross…